|
Index of reports
> Cases resulting in disability (7)
Below is the selection of adverse event reports related to Symbicort (Budesonide Inhalation) that includes cases resulting in disability.
Adverse event in 53 year old male receiving Symbicort (Budesonide Inhalation)
Reported by a physician from Netherlands on 2007-06-20
Patient: 53 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Deafness
Adverse event resulted in: disablity
Suspect drug(s):
Betamethasone Sodium Phosphate
Dosage: 0.5 mg; qd; o
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-02-26
Fluticasone Propionate
Dosage: 50 mcg;
Indication: Drug USE FOR Unknown Indication
Start date: 2005-11-17
Nasonex
Dosage: 1 df; qd; nas
Indication: Drug USE FOR Unknown Indication
Start date: 2006-06-19
Prednisolone
Dosage: 30 mg; qd
Indication: Drug USE FOR Unknown Indication
Start date: 2005-12-22
Symbicort
Dosage: 2 df; qd; inh
Indication: Drug USE FOR Unknown Indication
Start date: 2005-10-17
Other drugs received by patient: Xyzal; Singulair / 01362601 /
Adverse event in 41 year old male receiving Symbicort (Budesonide Inhalation)
Reported by a pharmacist from Canada on 2007-06-08
Patient: 41 year old male
Adverse reactions / side effects: Dyspnoea Exertional, Dyspnoea, Drug Ineffective
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Symbicort (Budesonide Inhalation)
Other drugs received by patient: Clonazepam; Citalopram; Naproxen
Adverse event in 53 year old male receiving Symbicort (Budesonide Inhalation)
Reported by a pharmacist from Netherlands on 2007-06-07
Patient: 53 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Deafness
Adverse event resulted in: disablity
Suspect drug(s):
Betamethasone Sodium Phosphate
Dosage: 0.5 mg; qd; po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-02-26
Flixonase (Fluticasone Propionate)
Dosage: 50 mcg;
Indication: Drug USE FOR Unknown Indication
Start date: 2005-11-17
Nasonex
Dosage: 1 df; qd; nas
Indication: Drug USE FOR Unknown Indication
Start date: 2006-06-19
Prednisolonum (Prednisolone)
Dosage: 30 mg; qd;
Indication: Drug USE FOR Unknown Indication
Start date: 2005-12-22
Symbicort
Dosage: 2 df; qd; inh
Indication: Drug USE FOR Unknown Indication
Start date: 2005-10-17
Other drugs received by patient: Xyzal; Singulair / 01362601 /
Adverse event in 646 month old male receiving Symbicort (Budesonide Inhalation)
Reported by a pharmacist from Netherlands on 2007-05-24
Patient: 646 month old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Deafness
Adverse event resulted in: disablity
Suspect drug(s):
Celestone
Administration route: Oral
Start date: 2006-02-26
Flixonase Neusspray
Start date: 2005-11-17
Nasonex Neusspray
Start date: 2006-06-19
Prednisolonum
Administration route: Oral
Start date: 2005-12-22
Symbicort
Dosage: 400/12 ug, 1 inhalation bid
Start date: 2005-10-17
Other drugs received by patient: Cetirizine HCL; Singulair
Adverse event in 41 year old male receiving Symbicort (Budesonide Inhalation)
Reported by a pharmacist from Canada on 2007-05-17
Patient: 41 year old male
Adverse reactions / side effects: Dyspnoea Exertional, Dyspnoea, Drug Ineffective
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Symbicort (Budesonide Inhalation)
Other drugs received by patient: Clonazepam; Citalopram Hydrobromide; Naproxen
Adverse event in 41 year old male receiving Symbicort (Budesonide Inhalation)
Reported by a pharmacist from Canada on 2007-05-10
Patient: 41 year old male
Adverse reactions / side effects: Dyspnoea Exertional, Dyspnoea, Drug Ineffective
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Symbicort (Budesonide Inhalation)
Other drugs received by patient: Clonazepam; Citalopram Hydrobromide; Naproxen
Adverse event in 411 month old male receiving Symbicort (Budesonide Inhalation)
Reported by a physician from France on 2007-04-06
Patient: 411 month old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Osteonecrosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Symbicort (Budesonide Inhalation)
|
